WXXWY
WUXI BIOLOGICS UNSP/ADRstockOTCADR
wuxi biologics provides an open-access, integrated technology platform for biologics drug development. we are the only true service platform in the world offering end-to-end solutions to empower anyone to discover, develop and manufacture biologics from concept to commercial manufacturing. our single-source approach to biologics development saves our clients critical time and money. see below how our experience, capacities and quality make us a world leading (cdmo). experience wuxi biologics' leadership team consists of industry experts with 15-20 years of experience in biological drug development in the u.s./eu. while at wuxi this team has contributed to 1 bla and 66 worldwide inds in just 3 years! expertise wuxi biologics has over 170+ returnees from large pharma and small biotechs in the u.s./eu. these scientists cover all facets of drug development from discovery to manufacture of final drug product. capacity and capabilities we have strong technical capabilities and an open-access
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 12.32 | 2026-11-12 | -7.63% | -0.175 |
| 1M | 12.24 | 2026-10-19 | -7.00% | 1.432 |
| 3M | 12.32 | 2026-08-19 | -7.63% | 1.551 |
| 6M | 8.30 | 2026-05-19 | +37.11% | 1.275 |
| 1Y | 8.07 | 2025-11-19 | +41.02% | 1.098 |
| 2Y | 3.85 | 2024-11-19 | +195.58% | — |
| 5Y | 28.36 | 2021-11-19 | -59.87% | 0.577 |
WUXI BIOLOGICS UNSP/ADR (OTC:WXXWY) stock price today is $11.38, and today's volume is 134,570. WXXWY is down 2.150% today. The 30 day average volume is 61,648. WXXWY market cap is $23.63B with 2.08B shares outstanding.